Health in Latvia 1,135 indicators covering health for Latvia. IndicatorLatest Year10-yr change Rank Maternal mortality vs neonatal mortality 18.32 2020 down 27.9% 127th Maternal deaths by income group 3.3 2020 down 35.1% 156th Maternal mortality vs fertility 18.32 2020 down 27.9% 127th Maternal deaths ihme 3.3 2020 down 35.1% 156th Maternal mortality ratio vs mean daily income 18.32 2020 down 27.9% 126th Proportion of population with primary reliance on fuels and 46.8% 2023 up 17.5% 67th Population with primary reliance on fuels and technologies for 0.2757 2023 up 7.3% 87th Hib (Hib3) immunization coverage among 1-year-olds (%) 99.0% 2025 up 5.3% 1st Diphtheria tetanus toxoid and pertussis third-dose (DTP3) 99.0% 2025 up 5.3% 1st Measles-containing-vaccine first-dose (MCV1) immunization coverage 99.0% 2025 up 3.1% 1st Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 99.0% 2025 up 5.3% 1st Measles-containing-vaccine second-dose (MCV2) immunization coverage 90.0% 2025 down 2.2% 69th Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 99.0% 2025 up 2.1% 1st Implementation of tools to monitor economic and environmental tourism 6 2021 unchanged 29th New HIV infections 0.1 2025 down 56.5% 70th Stunting prevalence among children under 5 years of age (%) 1.7% 2024 down 15.0% 153rd Stunting numbers among children under 5 years of age (millions) 1.4 2024 down 30.0% 151st Overweight numbers among children under 5 years of age (thousands) 5.5 2024 down 8.3% 138th Overweight prevalence among children under 5 years of age (%) 6.6% 2024 up 10.0% 69th Mean HDL cholesterol, age-standardized 1.5 2018 unchanged 3rd Mean total cholesterol, crude 5.3 2018 down 1.9% 1st Mean Non-HDL cholesterol, age-standardized 3.7 2018 down 7.5% 12th Mean HDL cholesterol, crude 1.5 2018 unchanged 3rd Mean Non-HDL cholesterol, crude 3.8 2018 down 7.3% 7th Mean total cholesterol, age-standardized 5.1 2018 down 3.8% 3rd Infant mortality rates by NUTS 2 region 1.5 2024 down 60.5% 35th Prevalence of anemia among children 19.4% 2019 down 8.9% 142nd Life expectancy by age, sex and NUTS 2 region 76.4 2024 up 2.8% 35th Births attended by skilled health staff 99.9% 2017 up 0.5% 16th Births attended by health staff sdgs 99.9 2017 up 0.5% 16th Number of deaths among children ages 10 to 14 years 9 2021 down 52.6% 164th Adolescent mortality rate 0.4617 2021 down 54.7% 167th Adults (ages 15+) living with HIV 6,000 2024 down 1.6% 108th Prevalence of current tobacco use 34.6% 2024 down 8.5% 15th Prevalence of current tobacco use, females 21.9% 2024 down 6.4% 24th Prevalence of current tobacco use, males 47.2% 2024 down 9.6% 21st BCG immunization coverage among 1-year-olds (%) 99.0% 2025 up 6.5% 1st Physicians per 1000 people 3.4 2022 up 8.1% 50th Physicians 3.4 per 1,000 people 2022 up 8.1% 50th Share of the population infected with hiv 0.5183 2024 down 11.9% 63rd Global vaccination coverage 99 2024 up 7.6% 1st Proportion of population with primary reliance on clean fuels and 81.0% 2024 up 19.1% 101st Under-five mortality rate, by sex 2.5 per 1,000 live births 2024 down 55.1% 170th Infant mortality rate 2.15 per 1,000 live births 2024 down 54.0% 168th Neonatal mortality rate 1.2 per 1,000 live births 2024 down 59.5% 172nd Infant mortality by NUTS 2 region 19 2024 down 77.1% 34th Number of incident tuberculosis cases 390 2024 down 64.5% 144th Incidence of tuberculosis 21 2024 down 63.2% 121st Number of incident tuberculosis cases 1 2024 down 99.5% 161st Number of deaths due to tuberculosis, excluding HIV 51 2024 down 26.1% 126th Deaths due to tuberculosis among HIV-negative people 2.7 2024 down 22.9% 98th Tuberculosis deaths by hiv status 0 2024 down 100.0% 162nd Tuberculosis case fatality rate 13 2024 unchanged 75th Life satisfaction vs child mortality 6.37 2025 up 14.5% 48th Incidence of tuberculosis sdgs 21 2024 down 63.2% 126th Tuberculosis deaths region 51 2024 down 63.6% 128th Tuberculosis death rate 2.7 2024 down 62.5% 113th Tuberculosis deaths who 51 2024 down 63.6% 128th Tuberculosis incidence 21 per 100,000 people 2024 down 63.2% 113th Tuberculosis patients with hiv share 0.36 2024 down 98.1% 159th ← Previous Page 9 of 19 Next →